Document:

formofagreement092211.htm

Exhibit 10.1

RAPTOR PHARMACEUTICAL CORP.

2010 STOCK INCENTIVE PLAN

____________________________

 

Award Agreement

____________________________

 

You are hereby awarded this stock option (“Option”) to purchase Shares of Raptor Pharmaceutical Corp. (the “Company”), subject to the terms and conditions set forth in this Stock Option Award Agreement (the “Award Agreement”) and in the Raptor Pharmaceutical Corp. 2010 Stock Incentive Plan (the “Plan”).  A copy of the Plan is attached as
Exhibit A, and a prospectus describing the Plan’s material terms is attached as Exhibit B.  Terms below that begin with capital letters have the special meaning set forth in the Plan or in this Award Agreement.

 

This Award is conditioned on your execution of this Award Agreement within 10 days after the Grant Date specified in Section 1 below.  By executing this Award Agreement, you will be irrevocably agreeing that all of your rights under this Award will be determined solely and exclusively by reference to the terms and conditions of the Plan, subject to the provisions set forth below.  As a result, you should not execute this Award Agreement until you
have carefully considered the terms and conditions of the Plan and this Award, plus the information disclosed within the attached Plan prospectus, and (ii) consulted with your personal legal and tax advisors about all of these documents.

 

1. Specific Terms.  Your Option has the following terms:

 

	
Name of Participant

	
[ ______________________________ ]

	
Type of Option:

	
 Incentive Stock Option (ISO)1

 Non-Incentive Stock Option (non-ISO)2

	
Grant Date:

	
[ ________ ] [ __ ], 20__.

	
Expiration Date:

	
 [   ]10 years after Grant Date, at 5:00 p.m EST. on the Expiration Date.

 [   ] 5 years after Grant Date, at 5:00 p.m. EST. on the Expiration Date.

	
Exercise Price:

	
U.S. $___.___  per Share

	
Number of Shares Subject to Award:

	
[ _______ ]

	
Vesting:

	
Your Award will vest, and thereby become exercisable with respect to the number of Shares covered by this Award,  at the rate of ___ (1/_)  on each of the first _____ annual anniversary dates of the Grant Date, provided that your Continuous Service has not ended before the particular vesting date (subject to any employment agreement between you and the Company).

	
Lifetime Transfer:

	
 Allowed for Non-ISOs pursuant to Section 8 of the Plan.

 Not allowed.

	
Recoupment

	
 Section 10 of the Plan shall apply regarding Recoupment of this Award.

 

1 If you directly or indirectly own more than 10% of the voting power of all classes of stock of the Company or of any Subsidiary, then the term of your ISO cannot exceed 5 years and the exercise price must be at least 110% of the Fair Market Value (100% for any other employee who is receiving ISO awards). Only employees may receive ISOs.

 

2 The exercise price of a non-ISO must be at least 100% of the Fair Market Value of the underlying Shares.

 

  

  

 

2. Manner of Exercise.  This Option shall be exercised in the manner set forth in the Plan, using the exercise form attached hereto as Exhibit C.  The amount of Shares for which this Option may be exercised is cumulative; that is, if you do not exercise this Option for all of the Shares vested under this Option during any period set forth above, then any
Shares subject hereto that are not exercised during such period may be exercised during any subsequent period, until the expiration or termination of this Option pursuant to Sections 1 and 4 of this Award Agreement and the terms of the Plan.  Fractional Shares may not be purchased.

 

3. Special ISO Provisions.  If designated as an ISO, this Option shall be treated as an ISO to the extent allowable under Section 422 of the Code, and shall otherwise be treated as a Non-ISO.  If you sell or otherwise dispose of Shares acquired upon the exercise of an ISO within 1 year from the date such Shares were acquired or 2 years from the Grant Date, you agree to deliver a written report to the Company within 10 days following the sale or other disposition of such Shares detailing the
net proceeds of such sale or disposition.

 

4. Termination of Continuous Service.  Subject to the terms of any employment agreement between you and the Company and/or any Affiliate that is in effect when your Continuous Service terminates, to the extent unvested, this Award shall be canceled and become automatically null and void coincident with termination of your Continuous Service.  Subject to the terms of any employment agreement between you and the Company and/or any Affiliate that is in effect when your Continuous Service
terminates, to the extent vested, this Award shall terminate, be cancelled and become automatically null and void after termination of your Continuous Service according to the following table:

 

	
Reason for Terminating Continuous Service

	
Option Termination Date

	
(I) By the Company for Cause, or what would have been Cause if the Company had known all of the relevant facts.

	
Termination of your Continuous Service, or when Cause first existed if earlier.

	
(II) You Die during Continuous Service or within 90 days thereafter or you are Disabled.

	
Eighteen months after termination of your Continuous Service.

	
(III) Your Retirement on or after Age 62.

	
Eighteen months after termination of your Continuous Service.

	
(IV)  You received these options as a non-employee member of the Board and your Board membership terminates other than due to Cause.

	
Eighteen months after termination of your Continuous Service

	
(V) Other than due to Cause or Your Disability, Retirement, or Death or pursuant to Clause (IV) above.

	
Ninety days after termination of your Continuous Service.

 

Notwithstanding anything to the contrary contained in this Section 4, no Option shall be exercisable after the Expiration Date set forth in Section 1.

 

-2-

 

  

  

  

5. Designation of Beneficiary.  Notwithstanding anything to the contrary contained herein or in the Plan, following the execution of this Award Agreement, you may expressly designate a death beneficiary (the “Beneficiary”) to your interest if any, in this Award and any underlying Shares.  You shall designate the Beneficiary by completing and executing a designation of beneficiary agreement substantially in the form
attached hereto as Exhibit D (the “Designation of Death Beneficiary”) and delivering an executed copy of the Designation of Beneficiary to the Company.  To the extent you do not duly designate a beneficiary who survives you, your estate will automatically be your beneficiary.

 

6. Restrictions on Transfer of Award. Your rights under this Award Agreement may not be sold, pledged, or otherwise transferred without the prior written consent of the Committee, except as hereinafter provided.  If Section 1 above allows you to make a transfer, such transfer must be in accordance with Section 8 of the Plan.  Any such transferee of your rights shall succeed and be subject to all of the terms of this Award Agreement and the Plan.

 

7. Taxes.  Except to the extent otherwise specifically provided in an employment or consulting agreement between you and the Company, by signing this Award Agreement, you acknowledge that you shall be solely responsible for the satisfaction of any taxes that may arise pursuant to this Award (including taxes arising under Sections 409A (regarding deferred compensation) or 4999 (regarding golden parachute excise taxes), and that neither the Company nor the Administrator shall have any obligation
whatsoever to pay such taxes or to otherwise indemnify or hold you harmless from any or all of such taxes.  The Committee shall have the sole discretion to interpret the requirements of the Code, including Section 409A, for purposes of the Plan and this Award Agreement.

 

8. Not a Contract of Employment.  By executing this Award, you acknowledge and agree that (i) any person who is terminated before full vesting of an award, such as the one granted to you by this Award Agreement, could claim that he or she was terminated to preclude vesting; (ii) you promise never to make such a claim; (iii) nothing in this Award Agreement or the Plan confers on you any right to continue an employment, service or consulting relationship with the Company, nor shall it affect in any way
your right or the Company’s right to terminate your employment, service, or consulting relationship at any time, with or without Cause; and (iv) the Company would not have granted this Award to you but for these acknowledgements and agreements.

 

-3-

 

  

  

  

9. Investment Purposes. By executing this Award Agreement, you represent and warrant that any Shares issued to you pursuant to this Option will be held for investment purposes only for your own account, and not with a view to, for resale in connection with, or with an intent in participating directly or indirectly in, any distribution of such Shares within the meaning of the Securities Act of 1933, as amended.

 

10. Securities Law Restrictions.  Regardless of whether the offering and sale of this Option or Shares under the Plan have been registered under the Securities Act of 1933, as amended (the “Securities Act”), or have been registered or qualified under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such Shares (including the placement of
appropriate legends on stock certificates or the imposition of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve compliance with the Securities Act or the securities laws of any state or any other law or to enforce the intent of this Award.

 

11. Headings.  Section and other headings contained in this Award Agreement are for reference purposes only and are not intended to describe, interpret, define or limit the scope or intent of this Award Agreement or any provision hereof.

 

12. Severability.  Every provision of this Award Agreement and of the Plan is intended to be severable.  If any term hereof is illegal or invalid for any reason, such illegality or invalidity shall not affect the validity or legality of the remaining terms of this Award Agreement.

 

13. Counterparts.  This Award Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument.

 

14. Notices.  Any notice or communication required or permitted by any provision of this Award Agreement to be given to you shall be in writing and shall be delivered electronically, personally, or sent by certified mail, return receipt requested, addressed to you at the last address that the Company had for you on its records.  Each party may, from time to time, by notice to the other party hereto, specify a new address for delivery of notices relating to this Award Agreement.  Any
such notice shall be deemed to be given as of the date such notice is personally or electronically delivered or properly mailed.

 

15. Binding Effect.  Except as otherwise provided in this Award Agreement or in the Plan, every covenant, term, and provision of this Award Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legatees, legal representatives, successors, transferees, and assigns.

 

16. Modifications.  This Award Agreement may be modified or amended at any time, in accordance with Section 14 of the Plan and provided that you must consent in writing to any modification that adversely and materially affects any rights or obligations under this Award Agreement.

 

17. Plan Governs.  By signing this Award Agreement, you acknowledge that you have received a copy of the Plan and that your Award Agreement is subject to all the provisions contained in the Plan, the provisions of which are made a part of this Award Agreement and your Award is subject to all interpretations, amendments, rules and regulations which from time to time may be promulgated and adopted pursuant to the Plan.  In the event of a conflict between the provisions of this Award Agreement
and those of the Plan, the provisions of the Plan shall control.

 

-4-

 

  

  

  

18. Governing Law.  The laws of the State of Delaware shall govern the validity of this Award Agreement, the construction of its terms, and the interpretation of the rights and duties of the parties hereto.

 

BY YOUR SIGNATURE BELOW, along with the signature of the Company’s representative, you and the Company agree that this Award is made under and governed by the terms and conditions of this Award Agreement and the Plan.

 

RAPTOR PHARMACEUTICAL CORP.

By:           

Name:                    Kim R. Tsuchimoto

Title:                     Chief Financial Officer

Date:                

 

PARTICIPANT

The undersigned Participant hereby accepts the terms of this Award Agreement and the Plan.

By:           

Name of Participant:                                                                                               

Date: 

 

-5-

  

  

  

Exhibit A

 

RAPTOR PHARMACEUTICAL CORP.

2010 STOCK INCENTIVE PLAN

____________________________

 

Plan Document

 

____________________________

 

  

  

  

Exhibit B

 

RAPTOR PHARMACEUTICAL CORP.

2010 STOCK INCENTIVE PLAN

____________________________

 

Plan Prospectus

 

____________________________

 

  

  

  

Exhibit C

 

RAPTOR PHARMACEUTICAL CORP.

2010 STOCK INCENTIVE PLAN

___________________________________________________

 

Form of Exercise of Stock Option Award Agreement

___________________________________________________

 

 

Raptor Pharmaceutical Corp.

9 Commercial Blvd., Suite 200

Novato, CA  94949

Attention:                                _______________________

Dear Sir or Madam:

 

The undersigned elects to exercise his/her Option to purchase _____ shares of Common Stock of Raptor Pharmaceutical Corp. (the “Company”) under and pursuant to a Stock Option Agreement dated as of ______________.

 

Delivered herewith is a certified or bank cashier’s or teller’s check in the amount of $__________.

 

The name or names to be on the stock certificate or certificates and the address and Social Security Number of such person(s) is as follows:

 

Name:                                                                                                                                          

 

Address:                                                                                                                                          

 

Social Security
No.:                                                                                                                                          

 

Very truly yours,

 

_________________                                                                

Date                                                      

 

Optionee

 

  

  

  

Exhibit D

 

RAPTOR PHARMACEUTICAL CORP.

2010 STOCK INCENTIVE PLAN

_________________________________

 

Designation of Death Beneficiary

_________________________________

 

In connection with the Awards designated below that I have received pursuant to the Raptor Pharmaceutical Corp. 2010 Stock Incentive Plan (the “Plan”), I hereby designate the person specified below as the beneficiary upon my death of my interest in such Awards.  This designation shall remain in effect until revoked in writing by me.

 

    Name of Beneficiary:                                           

         Address:                                

           Social Security No.:                                           

 

This beneficiary designation relates to any and all of my rights under the following Award or Awards:

 

         [   ] any Award that I have received or ever receive under the Plan.

 

	
  

	         [   ]   	
the _________________ Award that I received pursuant to an award agreement dated _________ __, ____ between myself and the Company.

 

I understand that this designation operates to entitle the above named beneficiary, in the event of my death, to any and all of my rights under the Award(s) designated above from the date this form is delivered to the Company until such date as this designation is revoked in writing by me, including by delivery to the Company of a written designation of beneficiary executed by me on a later date.

 

Date:           

 

By:           

Name of Participant

 

Sworn to before me this

____day of ____________, 20__

___________________________

Notary Public

County of     _________________

State of        __________________Exhibit 10.22

 

DEMAND NOTE

 

PRECISION OPTICS CORPORATION, INC.

July 13, 2011

 

This Demand Note Payable on Demand (the “Note) is made and effective as of July 13, 2011,

 

	
BETWEEN:
    	
Joseph N. Forkey (the “Lender”), an   individual
    
	
 
    	
 
    
	
AND:
    	
Precision Optics Corporation, Inc., a   Massachusetts corporation (the “Company”), having its principal place of   business at 22 East Broadway, Gardner, MA 01440.
    

 

FOR VALUE RECEIVED, the Company hereby unconditionally promises to pay to the order of the Lender, the principal sum of ten thousand United States Dollars ($10,000.00), without interest thereon, within one year from the date hereof. The entire principal shall be fully and immediately payable UPON DEMAND by the Lender at any time. By agreement of the undersigned, this Note shall be non interest-bearing.

 

The Lender may assign all of its rights, title and interest in, to and under this Note.

 

The Company has agreed to pay all reasonable and actual expenses incurred with the execution of this Note, including wire transfer fees.  Such fees will be itemized, in writing, to the Company.  In the event this Note is not paid when due, the Company promises to pay all costs and expenses, including reasonable attorney’s fees, incurred in connection with collection.

 

IN WITNESS WHEREOF, the undersigned has caused this Note to be duly executed as of the date first above written.

 

 

	
LENDER
    	
 
    	
PRECISION OPTICS CORPORATION, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
/s/ Joseph N. Forkey
    	
 
    	
By: 
    	
/s/ Jack P. Dreimiller
    
	
Joseph N. Forkey
    	
 
    	
Name:
    	
Jack P. Dreimiller
    
	
 
    	
 
    	
Title:
    	
Senior Vice President, Chief Financial   Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]